构建的融合蛋白是rtTA*M2的tetracycline响应域(来自Clontech的pTet-on Advanced)和SDKid-1的KRAB-AB沉默域(Clontech的pTet-tTS),命名为rtTS(tetracycline-controlled trans-silencer)。SA70b的pROSA-CAGGS-attP50/B53-hygro-NLSLacZ载体来自ARTEMIS Pharmaceuticals。从SA70b中去除CAGGS启动子和内含子片段,并插入到修改过的pROSA26质粒中,形成了pROSA26CAG-PAS载体。rtTS的cDNA被克隆进pBigT,再转接到pROSA26CAG-PAS,最终得到了定向到Rosa26的CAG-LSL-rtTS载体(J:255811)。

Basic Information

Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Gene Expression
Related Disease
Reference
129
Targeted
插入
--
--
--
1

Phenotypes

Legend:
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes:
Show/Hide columns
Phenotypes

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
微信
信息比对
科研助手
使用教程
回到顶部